Clinical Trials Browser

Triple Negative Breast Neoplasms

NCT04174599 2025-04-20

Study to Compare the Efficacy and Safety of F-627 and GRAN®

Phase 3 Completed

242 enrolled 41 charts

Breast

Breast Neoplasms, Neutropenia

NCT03197935 2023-10-26

IMpassion031

Phase 3 Completed

333 enrolled 18 charts

Breast

Triple Negative Breast Neoplasms

NCT03343145 2020-12-28

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Phase 3 Completed

143 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT00014222 2020-10-05

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Phase 3 Completed

2,104 enrolled 11 charts

Breast

Breast Neoplasms

NCT00003032 2020-04-01

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Phase 3 Completed

224 enrolled

Breast

Breast Neoplasms

NCT00002836 2018-11-06

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Phase 3 Completed

184 enrolled

Breast

Breast Neoplasms

NCT00590785 2017-08-25

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Phase 3 Completed

60 enrolled

Breast

Breast Neoplasms

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Phase 3 Completed

135 enrolled 18 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT01519700 2015-05-06

PIONEER

Phase 3 Completed

218 enrolled 15 charts

Breast

Breast Neoplasms, Neutropenia

NCT00002870 2014-12-16

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Phase 3 Completed

180 enrolled

Breast

Breast Neoplasms

NCT00002755 2013-11-06

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 3 Completed

600 enrolled

Breast

Breast Neoplasms

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Phase 3 Completed

1,856 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00002784 2013-04-04

15-95

Phase 3 Completed

344 enrolled

Breast

Breast Neoplasms

NCT00002772 2013-01-24

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 3 Terminated

602 enrolled

Breast

Breast Neoplasms

NCT00016406 2013-01-24

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Phase 3 Completed

399 enrolled

Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01079676 2012-10-16

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Phase 3 Completed

220 enrolled

Breast

Neutropenia in Breast Cancer

NCT00668616 2010-07-29

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes

Phase 3 Completed

1,034 enrolled

Breast

Breast Neoplasms

NCT00003972 2010-04-02

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer

Phase 3 Completed

280 enrolled

Breast

Breast Neoplasms

Clinical Trials

MK-3475-522

Study to Compare the Efficacy and Safety of F-627 and GRAN®

IMpassion031

A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

PIONEER

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

15-95

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

A Non-inferiority Study Comparing Two Filgrastim Preparations in Breast Cancer

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer